Merck withdraws EMA filing for asthma combo Zenhale – Pharma Times

Merck withdraws EMA filing for asthma combo Zenhale
Pharma Times
Merck & Co has decided to pull a submission for its new asthma treatment Zenhale in Europe, after the regulator required more data.

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *